Literature DB >> 26727671

[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

Marco Roffi1, Carlo Patrono, Jean-Philippe Collet, Christian Mueller, Marco Valgimigli, Felicita Andreotti, Jeroen J Bax, Michael A Borger, Carlos Brotons, Derek P Chew, Baris Gencer, Gerd Hasenfuss, Keld Kjeldsen, Patrizio Lancellotti, Ulf Landmesser, Julinda Mehilli, Debabrata Mukherjee, Robert F Storey, Stephan Windecker.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26727671     DOI: 10.5603/KP.2015.0243

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  13 in total

Review 1.  Dual antiplatelet therapy for secondary stroke prevention: Use of clopidogrel and acetylsalicylic acid after noncardioembolic ischemic stroke.

Authors:  Karolina Koziol; Vanessa Van der Merwe; Erin Yakiwchuk; Lynette Kosar
Journal:  Can Fam Physician       Date:  2016-08       Impact factor: 3.275

2.  Thrombus aspirated from patients with ST-elevation myocardial infarction: Clinical and angiographic outcomes.

Authors:  Yapan Yang; Jingchao Li; Wenke Xu; Shujuan Dong; Haijia Yu; Huihui Song; Yingjie Chu
Journal:  J Int Med Res       Date:  2016-11-11       Impact factor: 1.671

Review 3.  The impact of type 2 diabetes mellitus on prognosis in patients with non-ST elevation myocardial infarction.

Authors:  Katarzyna Birkner; Bartosz Hudzik; Mariusz Gąsior
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-06-30

4.  Combined Use of High-Sensitive Cardiac Troponin, Copeptin, and the Modified HEART Score for Rapid Evaluation of Chest Pain Patients.

Authors:  Beata Morawiec; Brygida Przywara-Chowaniec; Piotr Muzyk; Mariusz Opara; Lam Ho; Lui Chun Tat; Olivier Muller; Ewa Nowalany-Kozielska; Damian Kawecki
Journal:  Dis Markers       Date:  2018-11-12       Impact factor: 3.434

5.  Clinical presentation and treatment of acute coronary syndrome as well as 1-year survival of patients hospitalized due to cancer: A 7-year experience of a nonacademic center.

Authors:  Katarzyna Styczkiewicz; Marek Styczkiewicz; Monika Myćka; Sabina Mędrek; Tomasz Kondraciuk; Anna Czerkies-Bieleń; Andrzej Wiśniewski; Sebastian Szmit; Piotr Jankowski
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

6.  A novel risk score for predicting 6-months mortality at the time of hospital discharge in patients admitted with acute coronary syndrome.

Authors:  Anish John Padiyara; Rajneesh Kumar Calton
Journal:  Indian Heart J       Date:  2021-01-07

7.  Nurse-managed education: the effectiveness of secondary prevention after acute coronary syndromes and the prevalence and predictors of dropout from a cardiac rehabilitation programme.

Authors:  Agnieszka Sławska; Zbigniew Siudak
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-03-27       Impact factor: 1.426

8.  Associations between hyperhomocysteinemia and the presence and severity of acute coronary syndrome in young adults ≤ 35 years of age.

Authors:  Jiayin Sun; Wei Han; Sijing Wu; Shuo Jia; Zhenxian Yan; Yonghe Guo; Yingxin Zhao; Yujie Zhou; Wei Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-01-23       Impact factor: 2.298

9.  Association of frailty with all-cause mortality and bleeding among elderly patients with acute myocardial infarction: a systematic review and meta-analysis.

Authors:  Prapaipan Putthapiban; Wasawat Vutthikraivit; Pattara Rattanawong; Weera Sukhumthammarat; Napatt Kanjanahattakij; Jakrin Kewcharoen; Aman Amanullah
Journal:  J Geriatr Cardiol       Date:  2020-05       Impact factor: 3.327

10.  Parameters of Oxidative and Inflammatory Status in a Three-Month Observation of Patients with Acute Myocardial Infarction Undergoing Coronary Angioplasty-A Preliminary Study.

Authors:  Ewa Żurawska-Płaksej; Sylwia Płaczkowska; Lilla Pawlik-Sobecka; Hanna Czapor-Irzabek; Aneta Stachurska; Andrzej Mysiak; Tadeusz Sebzda; Jakub Gburek; Agnieszka Piwowar
Journal:  Medicina (Kaunas)       Date:  2019-09-13       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.